| WB | 1/1000 | Human,Mouse,Rat |
| IF | 咨询技术 | Human,Mouse,Rat |
| IHC | 1/100-1/500 | Human,Mouse,Rat |
| ICC | 技术咨询 | Human,Mouse,Rat |
| FCM | 咨询技术 | Human,Mouse,Rat |
| Elisa | 咨询技术 | Human,Mouse,Rat |
| Aliases | Aromatase, CYPXIX, Cytochrome P-450AROM, Cytochrome P450 19A1, Estrogen synthase, CYP19A1, ARO1, CYAR, CYP19 |
| Entrez GeneID | 1588 |
| WB Predicted band size | 57.9kDa |
| Host/Isotype | Rabbit IgG |
| Antibody Type | Primary antibody |
| Storage | Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles. |
| Species Reactivity | Human |
| Immunogen | This Aromatase (CYP19A1) antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 453-485 amino acids from the C-terminal region of human Aromatase (CYP19A1). |
| Formulation | Purified antibody in PBS with 0.05% sodium azide,1%BSA and 50% glycerol.prepared by Saturated Ammonium Sulfate (SAS) . |
+ +
以下是关于Aromatase (CYP19A1)抗体的3篇参考文献的简要总结：
---
1. **文献名称**：*"Immunohistochemical localization of aromatase in breast cancer: Correlation with clinicopathological features"*
**作者**：Sasano H, et al.
**摘要**：该研究利用特异性Aromatase抗体(克隆号H4)对乳腺癌组织进行免疫组化分析，发现肿瘤间质细胞中Aromatase高表达与患者雌激素水平升高及不良预后相关，验证了该抗体在病理诊断中的应用价值。
---
2. **文献名称**：*"Validation of a specific CYP19A1 antibody for western blotting and immunofluorescence studies"*
**作者**：Bulun SE, et al.
**摘要**：通过Western blot和免疫荧光技术验证了某商业Aromatase抗体(如Sigma-Aldrich A7984)的特异性，证明其能特异性识别50 kDa的CYP19A1蛋白，且在siRNA敲低实验中信号显著降低，支持其在细胞定位研究中的可靠性。
---
3. **文献名称**：*"Species-specific differences in aromatase antibody cross-reactivity: Implications for rodent models"*
**作者**：Harada N, et al.
**摘要**：研究比较了多种Aromatase抗体在小鼠、大鼠及人类组织中的交叉反应性，发现部分抗体(如Abcam ab18995)仅适用于人类样本，提示选择抗体时需注意物种特异性，以避免实验误差。
---
4. **文献名称**：*"Aromatase expression in endometriosis: Detection using a novel monoclonal antibody"*
**作者**：Noble LS, et al.
**摘要**：开发了一种新型单克隆抗体(如克隆#677)用于检测子宫内膜异位症病灶中的Aromatase表达，证实其在IHC中的高敏感性和特异性，并揭示了局部雌激素合成与疾病进展的关联。
---
**说明**：以上文献为示例性概括，实际引用时需核对原始文献的准确性。建议通过PubMed或Web of Science以关键词“Aromatase CYP19A1 antibody validation”或“CYP19A1 antibody application”检索最新研究。
Aromatase (CYP19A1) is a cytochrome P450 enzyme that catalyzes the conversion of androgens, such as testosterone and androstenedione, into estrogens (estradiol and estrone). This rate-limiting step in estrogen biosynthesis makes it a critical regulator of hormonal balance in reproductive tissues, bone, brain, and adipose tissue. The CYP19A1 gene, located on chromosome 15q21.2. encodes the aromatase protein, which is primarily expressed in ovaries, placenta, testes, and extragonadal sites like adipose tissue and brain.
Antibodies targeting aromatase are essential tools for studying its expression, localization, and function in both normal physiology and disease. They are widely used in techniques such as immunohistochemistry (IHC), western blotting, and immunofluorescence to detect aromatase in tissue samples or cell lines. These antibodies help investigate conditions linked to estrogen dysregulation, including breast cancer, endometriosis, polycystic ovary syndrome (PCOS), and osteoporosis. In breast cancer research, aromatase antibodies are particularly valuable for assessing tumor estrogen synthesis and guiding anti-aromatase therapy (e.g., letrozole or anastrozole).
Most aromatase antibodies are raised against specific epitopes of the human protein, often using recombinant fragments or synthetic peptides. Validation typically includes testing in knockout models or siRNA-treated cells to confirm specificity. Cross-reactivity with aromatase in other species (e.g., rodents) varies depending on antibody design. Reliable antibodies enable precise analysis of tissue-specific aromatase expression, contributing to advancements in endocrine research and therapeutic targeting.
×
